The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM...
The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort
About this item
Full title
Author / Creator
Damotte, Diane , Warren, Sarah , Arrondeau, Jennifer , Boudou-Rouquette, Pascaline , Mansuet-Lupo, Audrey , Biton, Jérôme , Ouakrim, Hanane , Alifano, Marco , Gervais, Claire , Bellesoeur, Audrey , Kramkimel, Nora , Tlemsani, Camille , Burroni, Barbara , Duche, Angéline , Letourneur, Franck , Si, Han , Halpin, Rebecca , Creasy, Todd , Herbst, Ronald , Ren, Xing , Morel, Pascale , Cesano, Alessandra , Goldwasser, François and Leroy, Karen
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
The 18-gene tumor inflammation signature (TIS) is a clinical research assay that enriches for clinical benefit to immune checkpoint blockade. We evaluated its ability to predict clinical benefit of immunotherapy in cancer patients treated with PD-1 checkpoint inhibitors in routine clinical care.
The CERTIM cohort is a prospective cohort which in...
Alternative Titles
Full title
The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort
Authors, Artists and Contributors
Author / Creator
Warren, Sarah
Arrondeau, Jennifer
Boudou-Rouquette, Pascaline
Mansuet-Lupo, Audrey
Biton, Jérôme
Ouakrim, Hanane
Alifano, Marco
Gervais, Claire
Bellesoeur, Audrey
Kramkimel, Nora
Tlemsani, Camille
Burroni, Barbara
Duche, Angéline
Letourneur, Franck
Si, Han
Halpin, Rebecca
Creasy, Todd
Herbst, Ronald
Ren, Xing
Morel, Pascale
Cesano, Alessandra
Goldwasser, François
Leroy, Karen
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b75c5fd83d2d4639a48bed140c36dd2f
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b75c5fd83d2d4639a48bed140c36dd2f
Other Identifiers
ISSN
1479-5876
E-ISSN
1479-5876
DOI
10.1186/s12967-019-2100-3
